Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, randomised, double-blind, placebo- and active-controlled trial

被引：6
|
作者：
Lieberman, J. A. [1 ]
Cutler, A. J. [2 ]
Wan, S. [3 ]
Migliore, R. [3 ]
Ruth, A. [4 ]
Laszlovszky, I. [5 ]
Nemeth, G. [5 ]
Durgam, S. [3 ]
机构：
[1] Columbia Univ Med Ctr, New York, NY 10032 USA
[2] Florida Clin Res Ctr LLC, Bradenton, FL USA
[3] Forest Res Inst, Jersey City, NJ 07311 USA
[4] Prescott Med Commun Grp, Chicago, IL USA
[5] Gedeon Richter Plc, Budapest, Hungary
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70756-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.033
引用
收藏
页码：S477 / S478
页数：2
相关论文
共 50 条
  • [41] A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation
    Ali Bin Sarwar Zubairi
    Nawal Salahuddin
    Ali Khawaja
    Safia Awan
    Adil Aijaz Shah
    Ahmed Suleman Haque
    Shahid Javed Husain
    Nisar Rao
    Javaid Ahmad Khan
    [J]. BMC Pulmonary Medicine, 13
  • [42] A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation
    Zubairi, Ali Bin Sarwar
    Salahuddin, Nawal
    Khawaja, Ali
    Awan, Safia
    Shah, Adil Aijaz
    Haque, Ahmed Suleman
    Husain, Shahid Javed
    Rao, Nisar
    Khan, Javaid Ahmad
    [J]. BMC PULMONARY MEDICINE, 2013, 13
  • [43] Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo- controlled, phase 3 trial
    Pozo-Rosich, Patricia
    Ailani, Jessica
    Ashina, Messoud
    Goadsby, Peter J.
    Lipton, Richard B.
    Reuter, Uwe
    Guo, Hua
    Schwefel, Brittany
    Lu, Kaifeng
    Boinpally, Ramesh
    Miceli, Rosa
    Ferreira, Rosa De Abreu
    Mccusker, Emily
    Yu, Sung Yun
    Severt, Lawrence
    Finnegan, Michelle
    Trugman, Joel M.
    [J]. LANCET, 2023, 402 (10404): : 775 - 785
  • [44] Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
    Barnes, Thomas R. E.
    Leeson, Verity C.
    Paton, Carol
    Costelloe, Ceire
    Simon, Judit
    Kiss, Noemi
    Osborn, David
    Killaspy, Helen
    Craig, Tom K. J.
    Lewis, Shon
    Keown, Patrick
    Ismail, Shajahan
    Crawford, Mike
    Baldwin, David
    Lewis, Glyn
    Geddes, John
    Kumar, Manoj
    Pathak, Rudresh
    Taylor, Simon
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2016, 20 (29) : 1 - +
  • [45] Asenapine in acute mania: A randomized, double-blind, placebo- and olanzapine-controlled trial (ARES 7501004)
    Panagides, John
    McIntyre, Roger S.
    Alphs, Larry
    Cohen, Miriam
    Lancaster, Scott
    Macek, Tom
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 222S - 223S
  • [46] Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial
    Reuter, Uwe
    Ehrlich, Marc
    Gendolla, Astrid
    Heinze, Axel
    Klatt, Jan
    Wen, Shihua
    Hours-Zesiger, Peggy
    Nickisch, Jacqueline
    Sieder, Christian
    Hentschke, Christian
    Maier-Peuschel, Monika
    [J]. CEPHALALGIA, 2022, 42 (02) : 108 - 118
  • [47] Cariprazine in the treatment of acute mania in bipolar disorder : A double-blind, placebo-controlled, phase III trial
    Bose, A.
    Starace, A.
    Wang, Q.
    Diaz, E.
    Goodman, J.
    Ruth, A.
    Nemeth, G.
    Laszlovszky, I.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 111 - 112
  • [48] Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
    Nemeth, Gyorgy
    Laszlovszky, Istvan
    Czobor, Pal
    Szalai, Erzsebet
    Szatmari, Balazs
    Harsanyi, Judit
    Barabssy, Agota
    Debelle, Marc
    Durgam, Suresh
    Bitter, Istvan
    Marder, Stephen
    Fleischhacker, W. Wolfgang
    [J]. LANCET, 2017, 389 (10074): : 1103 - 1113
  • [49] DRUG ABUSE POTENTIAL OF DIMEBON: A RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE PLACEBO- AND ACTIVE-CONTROLLED CROSSOVER STUDY IN HEALTHY RECREATIONAL POLYDRUG USERS
    Schoedel, K. A.
    Cronenberger, C.
    Corrigan, B.
    Fullerton, T.
    Fang, J.
    Martin, N.
    Ryan, N.
    Lopez, R.
    Mordenti, J.
    Smith, I.
    Sellers, E. M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S42 - S42
  • [50] Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: a double-blind, placebo-controlled trial
    Durgam, S.
    Earley, W.
    Li, R.
    Li, D.
    Lu, K.
    Laszlovszky, I.
    Fleischhacker, W. W.
    Lieberman, J. A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S512 - S513
12345